Who makes ZEP-3Na 0.1%?

ZEP-3Na 0.1% is developed by Shulov Innovate for Science Ltd. 2012.

Last reviewed 2026-04-19 · How we verify

ZEP-3Na 0.1%

Shulov Innovate for Science Ltd. 2012 · Phase 2 active Small molecule

At a glance

Generic name	ZEP-3Na 0.1%
Sponsor	Shulov Innovate for Science Ltd. 2012
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ZEP-3Na 0.1% CI brief — competitive landscape report
ZEP-3Na 0.1% updates RSS · CI watch RSS
Shulov Innovate for Science Ltd. 2012 portfolio CI